ASH Annual Meeting 2021- Focus on Lymphoma/DLBCL

The All-Virtual 63rd Annual Society of Hematology Annual Meeting & Exposition is scheduled for December 11-14, 2021. The conference will feature research findings about many hematologic conditions, including Lymphoma/DLBCL. Visit the ASH annual meeting website for more details.

Black Patients are Under-Represented in Pivotal CAR T-Cell Clinical Trials

Pivotal trials that supported Food and Drug Administration (FDA) approval of chimeric antigen receptor (CAR) T-cell therapies had low...

BELINDA: Tisa-Cel Noninferior to Standard of Care in Relapsed/Refractory Aggressive B-Cell NHL

According to results from the phase III BELINDA trial, patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (NHL) who received...
pink cancer cell

Pirtobrutinib in Patients With Previously Treated Mantle Cell Lymphoma

According to updated data from the phase I/II BRUIN study, presented at the 2021 American Society of Hematology Annual...

Hematology and Oncology News

Curated Journal Abstracts